A case of sensory ataxic Guillain–Barré syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer)
Toshihiko Fukushima, M Tomita, Satoshi Ikeda, Nobutaka Hattori
Topics & Concepts
Coronavirus disease 2019 (COVID-19)AntibodyGuillain-Barre syndromeMedicineVirology2019-20 coronavirus outbreakMessenger RNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyBiologyOutbreakGeneGeneticsInternal medicineInfectious disease (medical specialty)DiseasePeripheral Neuropathies and DisordersLong-Term Effects of COVID-19Myasthenia Gravis and Thymoma